Jordi Bach Tana

Title: The Innovative Contributions of Jordi Bach Tana

Introduction

Jordi Bach Tana is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address inflammatory and allergic diseases. With a total of two patents to his name, his work exemplifies the intersection of innovation and healthcare.

Latest Patents

Jordi's latest patents include "Tricyclic derivatives as LTD4 antagonists," which details compounds that are useful in the treatment or prevention of inflammatory and allergic diseases. These compounds, along with their pharmaceutically acceptable salts, are produced through specific manufacturing processes. Another significant patent is "Urea derivatives as integrin α4 antagonists," which introduces novel antagonists of the integrins α4β1 and α4β7. This patent outlines a general formula for these compounds, which are designed to target specific biological pathways.

Career Highlights

Jordi Bach Tana is currently associated with Laboratorios Almirall, S.A., where he continues to push the boundaries of pharmaceutical research. His work has not only contributed to the scientific community but has also paved the way for new therapeutic options for patients suffering from various conditions.

Collaborations

Throughout his career, Jordi has collaborated with esteemed colleagues, including Juan Miguel Jimenez Mayorga and Jesus Maria Ontoria Ontoria. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.

Conclusion

Jordi Bach Tana's contributions to the field of pharmaceuticals through his innovative patents highlight the importance of research and development in addressing health challenges. His work continues to inspire future advancements in medical science.